Ximing Yang

Professor and Chief of Urological Pathology

Northwestern Medicine
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (1)

Patient selection for focal therapy (FT) of prostate cancer requires the assessment of MRI and biopsy results. However, there is currently little guidance for the utility of PSMA PET/CT in FT planning. We describe the case of a man originally considered an ideal candidate for FT based on biopsy and MRI who was found to have a contralateral lesion‐harboring cancer detected only on PSMA PET/CT. Trial Registration: ClinicalTrials.gov identifier: NCT05852041

Year:

2025

Collaborators (2)

Ashley Ross

Northwestern University Feinberg School of Medicine

UNITED STATES
View details

Vikas Mehta

Attending Pathologist

Northwestern Medicine

UNITED STATES
View details